Chapel Disease Therapeutics Market Size is valued at USD 144.89 Mn in 2023 and is predicted to reach USD 161.10 Mn by the year 2031 at a 1.41% CAGR during the forecast period for 2024-2031. Chapel Syndrome is a rare genetic condition affecting the immune system. CHAPLE stands for "CD55 deficiency, hyperactivation, angiopathic thrombosis, and severe protein-losing enteropathy (PLE)." Chaple is characterized by severe protein-losing enteropathy,...
Report ID: 2360 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Omics-Based Clinical Trials Market Size is valued at USD 29.51 billion in 2023 and is predicted to reach USD 54.42 billion by the year 2031 at a 8.13% CAGR during the forecast period for 2023-2031. Omics-based clinical trials represent a significant shift towards more precise and personalized healthcare, offering the promise of better-targeted therapies with higher efficacy and fewer side effects. As the field evolves, continued advancements i...
Report ID: 2355 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Autoimmune Polyglandular Syndrome Type 1 Market Size is valued at USD 244.1 Mn in 2023 and is predicted to reach USD 389.6 Mn by the year 2031 at a 6.20% CAGR during the forecast period for 2024-2031. Autoimmune Polyglandular Syndrome type 1 is an uncommon autosomal recessive disorder characterized by hypoparathyroidism, adrenal insufficiency, and chronic mucocutaneous candidiasis. These are its three main manifestations. APS-1 does, nonethele...
Report ID: 2357 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
DNA/RNA Sample Extraction and Isolation Market Size is valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.14 Bn by the year 2031 at a 6.80% CAGR during the forecast period for 2024-2031. The extraction and isolation of DNA/RNA samples are critical operations in molecular biology and genetics research. They involve the extraction of nucleic acids (DNA and RNA) from cells, tissues, or biological fluids for use in PCR, seque...
Report ID: 2199 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
HIV-Associated Lipodystrophy Treatment Market Size is valued at USD 176.82 Mn in 2023 and is predicted to reach USD 239.62 Mn by the year 2031 at a 4.05% CAGR during the forecast period for 2024-2031. HIV-associated lipodystrophy is an unfavourable side effect of antiretroviral therapy (ART). Lipodystrophy, often HIV-associated lipodystrophy, is a disease unique to HIV-positive people. Facial, gluteal, thigh, and limb subcutaneous f...
Report ID: 2250 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Per-Encounter Medical Market Size is valued at USD 121.82 Bn in 2023 and is predicted to reach USD 377.93 Bn by the year 2031 at a 15.38% CAGR during the forecast period for 2024-2031. Per-encounter medical describes a billing model in which a healthcare practitioner charges a set amount for each patient encounter. This means the patient will always be charged the same amount for each appointment, no matter how long or complicated. ...
Report ID: 2253 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Botulinum Toxin in Urology Market Size is valued at USD 948.56 Mn in 2023 and is predicted to reach USD 1,504.89 Mn by the year 2031 at a 6.05% CAGR during the forecast period for 2024-2031. Botulinum toxin, commonly known as Botox, has found applications in the field of urology for the treatment of various medical conditions, particularly those related to the lower urinary tract. A range of significant factors drives the growth of ...
Report ID: 2255 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Medical Nitrous Oxide Market Size is valued at USD 1.76 Bn in 2023 and is predicted to reach USD 3.03 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2024-2031. Medical nitrous oxide, often known as N2O, is a colourless and odourless gas that has been utilized in medical settings for over a century. It is popularly referred to as "laughing gas" because of the euphoric effects it produces when inhaled in small doses. Nitrous ...
Report ID: 2329 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 180
The iPSC Characterization Kit Market Size is predicted to grow at an 15.54 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The advent of the iPSC characterization kit market arose for technological innovation, regulatory support, and collaborative partnerships that propel stem cell research forward. The increasing applications in research and therapy are expected to drive this marke...
Report ID: 1418 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 185
The FMS-like Tyrosine Kinase 3 Inhibitors Market Size is valued at 495.07 Million in 2023 and is predicted to reach 1455.43 Million by the year 2031 at a 14.74 % CAGR during the forecast period for 2024-2031. The effects of inhibitors have been documented in acute myeloid leukemia patients with FMS-like tyrosine kinase 3 inhibitors3 mutations, as part of the Non-Insured Health Benefits (NIHB) program. FMS-like tyrosine kinase 3...
Report ID: 1389 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 185
Pharmaceuticals